Ultragenyx Pharmaceutical INC Form 4 insider transactions

Theodore Alan Huizenga, SVP and Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., reports acquisition and disposal of common stock and stock options.

EVP and Chief Medical Officer Eric Crombez reports acquisition and disposal of Ultragenyx Pharmaceutical Inc. stock and stock options.

EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc., Erik Harris, reports acquisition and disposal of company stock and stock options.

Ultragenyx Pharmaceutical Inc.'s CEO, Emil Kakkis, reports acquisition and disposal of company stock and stock options.